BioAge Labs (BIOA) Cash Flow: Operating & Free Cash Flow

BioAge Labs Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for BioAge Labs, Inc. (BIOA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-80.61	-71.11	-63.85	-39.72
Depreciation & Amortization	0.21	0.17	0.16	0.13
Stock Based Compensation	11.69	6.98	3.02	2.54
Change in Working Capital	-11.83	11.18	6.71	0.80
Change in Accounts Receivable	-0.77	0.00	0.00	0.00
Change in Accounts Payable	0.79	0.01	-0.39	0.99
Change in Other Working Capital	-1.34	11.17	7.10	0.10
Other Operating Activities	-1.34	1.27	16.60	0.10
Net Cash from Operating Activities	-81.63	-51.52	-37.36	-36.18
Investing Activities
Capital Expenditures	-0.72	-0.37	-0.17	-0.10
Purchases of Investments	-154.75	0.00	-0.10	0.00
Sales/Maturities of Investments	60.25	0.00	0.00	0.00
Net Cash from Investing Activities	-95.22	-0.37	-0.27	-0.10
Financing Activities
Debt Repayment	-6.00	-6.00	35.00	2.50
Common Stock Issued	17.16	221.62	0.00	0.04
Other Financing Activities	-0.40	165.58	-0.06	-0.05
Net Cash from Financing Activities	11.47	381.20	34.94	2.50
Summary
Effect of Forex Changes on Cash	-0.09	0.08	0.00	0.25
Net Change in Cash	-165.46	329.39	-2.69	-33.54
Cash at Beginning of Period	354.35	24.96	27.64	61.18
Cash at End of Period	188.89	354.35	24.96	27.64
Free Cash Flow	-82.35	-51.89	-37.53	-36.28
Supplemental Disclosures
Interest Paid	-	1.42	1.16	0.13

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioAge Labs Cash Flow

What is BioAge Labs's free cash flow?

BioAge Labs had negative free cash flow of $82.35M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$81.63M minus $719.00K of capital expenditures.

How much does BioAge Labs spend on capital expenditures?

BioAge Labs spent $719.00K on capital expenditures in fiscal 2025, compared with $366.00K a year earlier.

Does BioAge Labs pay dividends or buy back shares?

BioAge Labs's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition